crenolanib

crenolanib
Trade Name
Orphan Indication Malignant glioma
USA Market Approval USA
USA Designation Date 2010-12-20 00:00:00
Sponsor AROG Pharmaceuticals, LLC;12400 Coit Road, Suite 570;Dallas, TX, 75251